(Q43220764)

16 November 2017

title

Soluble CD26/CD30 levels in visceral leishmaniasis: markers of disease activity (English)

1 reference

16 November 2017

main subject

visceral leishmaniasis

1 reference

S Ajdary

1

1 reference

16 November 2017

F Riazi-Rad

series ordinal

2

1 reference

16 November 2017

R Jafari-Shakib

series ordinal

3

1 reference

16 November 2017

M Mohebbali

series ordinal

4

1 reference

16 November 2017

publication date

1 July 2006

1 reference

Clinical and Experimental Immunology

16 November 2017

published in

1 reference

16 November 2017

volume

145

1 reference

16 November 2017

issue

1

1 reference

16 November 2017

page(s)

44-47

1 reference

Age, acquired immunity and the risk of visceral leishmaniasis: a prospective study in Iran

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03105.X

New perspectives on a subclinical form of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03105.X

In vivo and in vitro cytokine profiles and mononuclear cell subsets in Sicilian patients with active visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03105.X

Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03105.X

Soluble CD30 serum level in HCV-positive chronic active hepatitis: A surrogate marker of disease activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03105.X

Serum levels of soluble CD30 in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03105.X

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03105.X

The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03105.X

Th1 and Th2 in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03105.X

Soluble CD26/30 levels before and after treatment with interferon-alpha and ribavirin combination therapy in a pediatric hepatitis C patient.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1941995

Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1941995

Control of Leishmania infantum infection is associated with CD8(+) and gamma interferon- and interleukin-5-producing CD4(+) antigen-specific T cells

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1941995

Splenic cytokine responses in Indian kala-azar before and after treatment

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1941995

T-helper 2 involvement in the pathogenesis of bullous pemphigoid: role of soluble CD30 (sCD30).

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1941995

Interleukin 10 production correlates with pathology in human Leishmania donovani infections

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1941995

Potential role for interleukin-10 in the immunosuppression associated with kala azar

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1941995

Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1941995

Epidemiologic study of visceral leishmaniasis in Honduras, 1975-1983.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1941995

High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis

27 August 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03105.X

Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03105.X

Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferon-gamma production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03105.X

Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03105.X

MECHANISMS OF CD26/DIPEPTIDYL PEPTIDASE IV CYTOKINE-DEPENDENT REGULATION ON HUMAN ACTIVATED LYMPHOCYTES

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03105.X

Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03105.X

The role of IL-10 in promoting disease progression in leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03105.X

Interleukin-16 expression and release in bullous pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03105.X

Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis

21 January 2018

1 reference

12 December 2020

CD26 expression in leprosy and other granulomatous diseases correlates with the production of interferon-gamma

1 reference

12 December 2020

Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides

1 reference

12 December 2020

An endemic focus of visceral leishmaniasis in Meshkin-Shahr, east Azerbaijan province, north-west part of Iran and IFA serological survey of the disease in this area

1 reference

12 December 2020

10.1111/J.1365-2249.2006.03105.X

Identifiers

DOI

1 reference

16 November 2017

0 references

1 reference